Production (Stage)
Passage Bio, Inc.
PASG
$0.4228
-$0.0272-6.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 24.56M | 24.99M | 26.56M | 27.49M | 29.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 60.94M | 65.17M | 69.34M | 76.72M | 85.17M |
| Operating Income | -60.94M | -65.17M | -69.34M | -76.72M | -85.17M |
| Income Before Tax | -63.46M | -64.77M | -68.80M | -76.57M | -84.44M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -63.46 | -64.77 | -68.80 | -76.57 | -84.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.46M | -64.77M | -68.80M | -76.57M | -84.44M |
| EBIT | -60.94M | -65.17M | -69.34M | -76.72M | -85.17M |
| EBITDA | -58.46M | -62.09M | -66.17M | -73.35M | -81.62M |
| EPS Basic | -1.03 | -1.07 | -1.17 | -1.36 | -1.53 |
| Normalized Basic EPS | -0.56 | -0.62 | -0.68 | -0.78 | -0.90 |
| EPS Diluted | -1.03 | -1.07 | -1.17 | -1.36 | -1.53 |
| Normalized Diluted EPS | -0.56 | -0.62 | -0.68 | -0.78 | -0.90 |
| Average Basic Shares Outstanding | 247.41M | 241.60M | 234.62M | 227.65M | 220.65M |
| Average Diluted Shares Outstanding | 247.41M | 241.60M | 234.62M | 227.65M | 220.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |